-
Virtual Connection in a Time of Social DistanceResponding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
-
Cancer Treatment During a PandemicPeople being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
by William G. Nelson, MD, PhD
-
Testing Cancer Patients for the CoronavirusCancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
-
The Coronavirus Impacts Cancer Clinical TrialsThe National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
-
The Coronavirus and Cancer CareCancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
Following her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
Telehealth Palliative Care Provides the Same Benefits as In-person CareResearchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
Sensorimotor Training Helps Prevent Chemotherapy-induced Peripheral NeuropathyThe specialized balance training exercise can help keep the nervous system healthy during chemotherapy by giving it a workout.
by Sandra Gordon
What Is Liquid Biopsy?Blood tests, often called liquid biopsy, could be key to early cancer detection and monitoring response to treatment.
by Cancer Research Catalyst
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
